$148.10 $2.94 (2.0%)

04:00 PM EDT on 08/16/19

Alexandria Real Estate Equities, Inc. (NYSE:ARE)

CAPS Rating: 4 out of 5

The Company is engaged principally in the ownership, operation, management, selective redevelopment, development and acquisition of properties for the life sciences industry.

Current Price $148.10 Mkt Cap $16.6B
Open $145.49 P/E Ratio 0.00
Prev. Close $145.16 Div. (Yield) $3.94 (2.7%)
Daily Range $145.49 - $148.29 Volume 254,447
52-Wk Range $110.67 - $153.38 Avg. Daily Vol. 19

Caps

How do you think NYSE:ARE will perform against the market?

Add Stock to CAPS Watchlist

All Players

88 Outperform
52 Underperform
 

All-Star Players

28 Outperform
7 Underperform
 

Wall Street

13 Outperform
0 Underperform
 

Top NYSE:ARE Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFMattyA (99.82)
Submitted September 17, 2013

Alexandria Real Estate Equities (ARE) is the largest “life science” real estate company, serving major pharmaceutical, biotech, and medical sciences industries. At the end of 2012, ARE owned 178 properties, covering about 17 million rent-able square… More

Ewok82 (28.69)
Submitted May 25, 2009

Expensive property in a niche market for life science research seems to be a bit speculative in this market, especially given that some of these properties are in cities like SF, where prices continue to fall as taxes continue to rise.

NYSE:ARE VS S&P 500 (SPY)

Fools bullish on NYSE:ARE are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about ARE.

Recs

0
Member Avatar aetel (66.77) Submitted: 3/13/2019 8:32:46 PM : Outperform Start Price: $138.24 NYSE:ARE Score: +4.50

Growing company with a goal-driven leader taking a fresh approach towards targeting a growing sector that will continue to stay relevant and elemental to the evolution of mankind. Textbook approach applying the concept of skill clustering and playing off the needs of a specialized field with unique demands.

Watch for the falter in public, private and governmental support of research and funding of Biotech, Agtech and health research.

Recs

0
Member Avatar SolelyOnWhaIHear (80.69) Submitted: 3/7/2019 2:04:43 AM : Outperform Start Price: $134.82 NYSE:ARE Score: +5.54

Bio cluster

Recs

4
Member Avatar TMFMattyA (99.82) Submitted: 9/17/2013 3:16:52 PM : Outperform Start Price: $51.96 NYSE:ARE Score: +116.20

Alexandria Real Estate Equities (ARE) is the largest “life science” real estate company, serving major pharmaceutical, biotech, and medical sciences industries. At the end of 2012, ARE owned 178 properties, covering about 17 million rent-able square feet that were 93.4% leased. They own some of the largest life science properties in New York City, Boston, San Diego and Research Triangle Park in North Carolina.

ARE has crushed the market over the long-term and currently yields over 4%. REITs have been hit pretty bad lately with the recent rise in Treasury yields, so you're getting ARE at a bargain today. I think it's not only an exceptionally-managed REIT, but a great way to indirectly bet on biotech (without a lot of the additional risk).

Leaderboard

Find the members with the highest scoring picks in ARE.

Score Leader

SSPX3

SSPX3 (< 20) Score: +330.24

The Score Leader is the player with the highest score across all their picks in ARE.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
SSPX3 < 20 5/14/2009 Outperform NS $22.47 +559.08% +228.84% +330.24 0 Comment
czarl 55.68 5/27/2009 Outperform NS $25.62 +478.15% +219.09% +259.06 0 Comment
crabbucket1 < 20 5/4/2009 Outperform 3M $25.60 +478.47% +229.50% +248.97 1 Comment
TraderJFH 97.57 7/22/2009 Outperform 1Y $26.97 +449.06% +203.06% +246.00 0 Comment
NSHanlon 56.34 4/27/2009 Outperform 3Y $26.20 +465.19% +240.54% +224.65 0 Comment
mitchiemono 93.26 4/27/2009 4/24/2010 Outperform 3Y $26.20 +465.19% +240.54% +224.65 0 Comment
Lance03 93.81 3/9/2009 Outperform NS $22.93 +545.91% +332.44% +213.48 0 Comment
SSPXXX 70.35 6/8/2009 Outperform 5Y $29.20 +407.12% +210.91% +196.21 0 Comment
TMFMattyA 99.82 9/17/2013 Outperform 5Y $51.96 +185.03% +68.83% +116.20 1 Comment
BaseBawl 30.60 10/4/2013 Outperform 5Y $52.47 +182.24% +71.59% +110.65 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackCitigroup 85.70 12/3/2018 Outperform NS $122.30 +21.10% +3.02% +18.08 0 Comment
TrackJimCramer 86.43 8/2/2016 Outperform 3W $99.51 +48.84% +33.96% +14.88 0 Comment
TrackZacks < 20 2/23/2012 Underperform 3M $70.56 +0.58% -2.58% -3.16 6/8/2012 @ $70.97 1 Comment
TrackRBCCapMkts 84.33 6/21/2011 Outperform NS $60.20 +146.01% +124.95% +21.06 0 Comment
TrackGoldmanSach 75.43 12/20/2010 Outperform 5Y $52.38 +182.76% +131.67% +51.09 1 Comment
TrackBarclaysCap 88.41 3/4/2010 Outperform NS $46.36 +219.44% +156.78% +62.66 0 Comment
TrackDreman < 20 9/30/2009 Outperform NS $40.05 +269.82% +181.77% +88.05 0 Comment
TrackRWBaird 88.13 9/1/2009 Outperform NS $40.90 +262.14% +183.42% +78.72 0 Comment
TrackJMP 84.53 8/4/2009 Outperform NS $28.98 +410.96% +190.16% +220.80 0 Comment
TrackUBS 91.68 9/17/2008 Outperform NS $74.55 +98.67% +148.91% -50.24 0 Comment
TrackChrisDavis 92.83 6/3/2008 Outperform 1Y $70.81 +109.14% +114.96% -5.82 1 Comment
TrackRonBaron 78.58 3/31/2008 Outperform NS $63.80 +132.12% +126.90% +5.22 1 Comment
TrackHeebner < 20 12/31/2007 Outperform NS $69.37 +113.48% +105.82% +7.66 3 Comments
TrackCantorFitz 49.26 1/31/2007 Outperform NS $70.68 +109.54% +114.88% -5.34 0 Comment
TrackRBCCapMkts 84.33 11/7/2006 Underperform NS $83.56 -5.36% -7.08% -1.72 6/21/2011 @ $79.08 0 Comment
TrackRyanBeck < 20 10/26/2006 Outperform NS $86.60 +7.17% -6.02% +13.20 3/1/2007 @ $92.81 0 Comment